Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
Clin Mass Spectrom
; 14 Pt A: 34-45, 2019 Sep.
Article
in En
| MEDLINE
| ID: mdl-34934812
ADR, acquired drug resistance; DBS, dried blood spots; DS-TB, drug-susceptible tuberculosis; EMA, European Medicines Agency; FDA, Food and Drug Administration; HILIC, hydrophilic interaction liquid chromatography; HPLC, high performance liquid chromatography; LC-MS/MS; LC-MS/MS, liquid chromatography-tandem mass spectrometry; Liquid chromatography; MDR-TB, multidrug-resistant tuberculosis; MTB, Mycobacterium tuberculosis; Multi-analyte assays; SIL-IS, stable isotopically labelled-internal standards; TB, tuberculosis; TDM; TDM, therapeutic drug monitoring; Tuberculosis; UHPLC-UV, ultra-high performance liquid chromatography-ultra violet detection; WHO, World Health Organisation
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Mass Spectrom
Year:
2019
Document type:
Article
Affiliation country:
Sweden
Country of publication:
Netherlands